Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinicopathological and Genomic Identification of Breast Cancers with No Impact on Mortality.
Gámez-Casado S, Rodríguez-Pérez L, Bandera-López C, Mesas-Ruiz A, Campini-Bermejo A, Bernal-Gómez M, Zalabardo-Aguilar M, Calvete-Candenas J, Martínez-Bernal G, Atienza-Cuevas L, García-Rojo M, Benítez-Rodríguez E, Pajares-Hachero B, Bermejo-Pérez MJ, Baena-Cañada JM. Gámez-Casado S, et al. Among authors: bermejo perez mj. Cancers (Basel). 2024 Mar 7;16(6):1086. doi: 10.3390/cancers16061086. Cancers (Basel). 2024. PMID: 38539421 Free PMC article.
Clinicopathological characteristics and survival results of patients with ultralow risk breast cancer.
Baena-Cañada JM, Gámez-Casado S, Rodríguez-Pérez L, Bandera-López C, Mesas-Ruiz A, Campini-Bermejo A, Bernal-Gómez M, Zalabardo-Aguilar M, Calvete-Candenas J, Martínez-Bernal G, Quílez-Cutillas A, Atienza-Cuevas L, García-Rojo M, Benítez-Rodríguez E, Pajares-Hachero B, Bermejo-Pérez MJ. Baena-Cañada JM, et al. Among authors: bermejo perez mj. Med Clin (Barc). 2022 Oct 28;159(8):351-358. doi: 10.1016/j.medcli.2021.11.008. Epub 2022 Feb 16. Med Clin (Barc). 2022. PMID: 35181168 English, Spanish.
The Benefits of a Therapeutic Exercise and Educational Intervention Program on Central Sensitization Symptoms and Pain-Related Fear Avoidance in Breast Cancer Survivors.
Gutiérrez-Sánchez D, Pajares-Hachero BI, Trinidad-Fernández M, Escriche-Escuder A, Iglesias-Campos M, Bermejo-Pérez MJ, Alba-Conejo E, Roldán-Jiménez C, Cuesta-Vargas A. Gutiérrez-Sánchez D, et al. Among authors: bermejo perez mj. Pain Manag Nurs. 2022 Aug;23(4):467-472. doi: 10.1016/j.pmn.2022.01.003. Epub 2022 Mar 9. Pain Manag Nurs. 2022. PMID: 35277360 Free article.
Gut and Endometrial Microbiome Dysbiosis: A New Emergent Risk Factor for Endometrial Cancer.
Boutriq S, González-González A, Plaza-Andrades I, Laborda-Illanes A, Sánchez-Alcoholado L, Peralta-Linero J, Domínguez-Recio ME, Bermejo-Pérez MJ, Lavado-Valenzuela R, Alba E, Queipo-Ortuño MI. Boutriq S, et al. Among authors: bermejo perez mj. J Pers Med. 2021 Jul 14;11(7):659. doi: 10.3390/jpm11070659. J Pers Med. 2021. PMID: 34357126 Free PMC article. Review.
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
Cortés J, Kim SB, Chung WP, Im SA, Park YH, Hegg R, Kim MH, Tseng LM, Petry V, Chung CF, Iwata H, Hamilton E, Curigliano G, Xu B, Huang CS, Kim JH, Chiu JWY, Pedrini JL, Lee C, Liu Y, Cathcart J, Bako E, Verma S, Hurvitz SA; DESTINY-Breast03 Trial Investigators. Cortés J, et al. N Engl J Med. 2022 Mar 24;386(12):1143-1154. doi: 10.1056/NEJMoa2115022. N Engl J Med. 2022. PMID: 35320644 Clinical Trial.
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA; DESTINY-Breast04 Trial Investigators. Modi S, et al. N Engl J Med. 2022 Jul 7;387(1):9-20. doi: 10.1056/NEJMoa2203690. Epub 2022 Jun 5. N Engl J Med. 2022. PMID: 35665782 Free PMC article. Clinical Trial.
Survival with Cemiplimab in Recurrent Cervical Cancer.
Tewari KS, Monk BJ, Vergote I, Miller A, de Melo AC, Kim HS, Kim YM, Lisyanskaya A, Samouëlian V, Lorusso D, Damian F, Chang CL, Gotovkin EA, Takahashi S, Ramone D, Pikiel J, Maćkowiak-Matejczyk B, Guerra Alía EM, Colombo N, Makarova Y, Rischin D, Lheureux S, Hasegawa K, Fujiwara K, Li J, Jamil S, Jankovic V, Chen CI, Seebach F, Weinreich DM, Yancopoulos GD, Lowy I, Mathias M, Fury MG, Oaknin A; Investigators for GOG Protocol 3016 and ENGOT Protocol En-Cx9. Tewari KS, et al. N Engl J Med. 2022 Feb 10;386(6):544-555. doi: 10.1056/NEJMoa2112187. N Engl J Med. 2022. PMID: 35139273 Clinical Trial.
[Complete response in a patient with a metastatic cutaneous melanoma].
Bermejo-Pérez MJ, Villar-Chamorro E, Lemos-Simosomo M, García-González C, Galeote-Miguel AM. Bermejo-Pérez MJ, et al. An Sist Sanit Navar. 2011 May-Aug;34(2):307-10. doi: 10.4321/s1137-66272011000200018. An Sist Sanit Navar. 2011. PMID: 21904414 Free article. Spanish.
15 results